SCHEMBL5878817

SCHEMBL5878817

CCCC(CC)CCCCCCCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
FFAR4 Q5NUL3 2/20 0.58
FFAR1 O14842 2/20 0.58
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
PTPN1 P18031 3/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56
PDE4A P27815 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085237 1.00 ALDH1A1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL16212859 1.00 ALDH1A1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL7783543 1.00 ALDH1A1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL16212711 1.00 ALDH1A1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL27752861 1.00 ALDH1A1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL2999103 0.98 ALDH1A1 (0.58) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL2483230 0.94 GSTK1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL6439923 0.94 GSTK1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL2575563 0.94 GSTK1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL3142455 0.94 GSTK1 (0.61) ALDH1A1FFAR4FFAR1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153869-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2005-07-14 US claimed
US-20040097392-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-20 US claimed
US-20040092418-A1 Fatty acids, soaps surfactant systems, and consumer products based thereon CONNOR DANIEL STEDMAN (US) 2004-05-13 US claimed
US-20040092419-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-13 US claimed
US-20040087461-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-06 US claimed
JP-2001520304-A 2001-10-30 JP claimed
CN-1283219-A Fatty acids, soaps, surfactant systems and consumer products based thereon PROCTER & GAMBLE (US) 2001-02-07 CN claimed
EP-1025190-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 2000-08-09 EP claimed
WO-1999020722-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 1999-04-29 WO claimed
EP-2992031-B1 ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS NOVOMER INC (US) 2022-10-05 EP disclosed
US-20190240235-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERY LIPOCINE INC. (US) 2019-08-08 US disclosed
US-9738760-B2 Aliphatic polycarbonate compositions and methods NOVOMER, INC. (US) 2017-08-22 US disclosed
CN-105518053-B aliphatic polycarbonate compositions and methods 诺沃梅尔公司 2017-07-21 CN disclosed
US-20170020893-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERY LIPOCINE INC. (US) 2017-01-26 US disclosed
US-6602845-B2 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2003-08-05 US disclosed
US-20030100469-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon CONNOR DANIEL STEDMAN (US) 2003-05-29 US disclosed
US-6395701-B1 MIXTURE PROCTER & GAMBLE COMPANY, THE 2002-05-28 US disclosed
CN-1283219-A Fatty acids, soaps, surfactant systems and consumer products based thereon PROCTER & GAMBLE (US) 2001-02-07 CN disclosed
EP-1025190-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 2000-08-09 EP disclosed
WO-1999020722-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 1999-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240235-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERY SHBG, CYP17A1, LIPE ALDH1A1 993/4885FFAR4 258/4885FFAR1 200/4885
US-20170020893-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERY SHBG, CYP17A1, CYP19A1 ALDH1A1 1054/4885FFAR4 276/4885FFAR1 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.